O
MGNX icon

OppenheimerFunds’s MacroGenics MGNX Stock Holding History

OppenheimerFunds’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$80.3M Buy
4,463,410
+16,569
+0.4% +$286K 0.1% 212
2018
Q4 		$56.5M Buy
4,446,841
+359,061
+9% +$6.02M 0.08% 248
2018
Q3 		$87.6M Sell
4,087,780
-21,760
-0.5% -$464K 0.1% 221
2018
Q2 		$84.9M Buy
4,109,540
+160,170
+4% +$3.61M 0.1% 222
2018
Q1 		$99.4M Buy
3,949,370
+15,464
+0.4% +$376K 0.12% 181
2017
Q4 		$74.7M Buy
3,933,906
+384,861
+11% +$7.18M 0.09% 231
2017
Q3 		$65.6M Sell
3,549,045
-33,817
-0.9% -$586K 0.08% 261
2017
Q2 		$62.7M Buy
3,582,862
+259,837
+8% +$4.96M 0.08% 260
2017
Q1 		$61.8M Buy
3,323,025
+286,018
+9% +$5.52M 0.07% 265
2016
Q4 		$62.1M Buy
3,037,007
+36,187
+1% +$911K 0.08% 266
2016
Q3 		$89.8M Buy
3,000,820
+20,160
+0.7% +$600K 0.11% 211
2016
Q2 		$80.4M Buy
2,980,660
+91,076
+3% +$2.05M 0.11% 232
2016
Q1 		$54.2M Buy
2,889,584
+640
+0% +$12.2K 0.07% 290
2015
Q4 		$89.5M Buy
2,888,944
+472,320
+20% +$14.3M 0.11% 195
2015
Q3 		$51.8M Buy
2,416,624
+2,160,421
+843% +$67.8M 0.07% 324
2015
Q2 		$9.73M Buy
+256,203
New +$8.42M 0.01% 760

Other funds holding MGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OppenheimerFunds's MGNX Position: Q1 2019 in Review

OppenheimerFunds increased its MacroGenics (MGNX) stake by 0.37% in Q1 2019, buying an estimated $286K and bringing the position to 4,463,410 shares worth $80.3M. The position accounts for 0.1% of the portfolio, ranked #212.

OppenheimerFunds first reported a position in MGNX in Q2 2015 and has held it in 16 quarters since. The position peaked at $99.4M in Q1 2018. 157 funds tracked by Wall St. Rank hold MGNX as of Q1 2019.

  • OppenheimerFunds held 4,463,410 shares of MacroGenics worth $80.3M as of Q1 2019.
  • OppenheimerFunds bought 16,569 MacroGenics shares in Q1 2019, an estimated $286K.
  • MacroGenics made up 0.1% of OppenheimerFunds's portfolio in Q1 2019, its #212 holding.
  • OppenheimerFunds first reported a position in MacroGenics in Q2 2015 and has held it in 16 quarters since.
  • OppenheimerFunds's MacroGenics position peaked at $99.4M in Q1 2018.
  • 157 funds tracked by Wall St. Rank held MacroGenics as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.